Elite Pharmaceuticals, Inc. Long-Term Debt, Maturity, after Year Five
Elite Pharmaceuticals, Inc. (ELTP) had Long-Term Debt, Maturity, after Year Five of $735.00 thousand as of 2022-03-31, per its 10-Q filed 2022-11-14.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive · last filed 2022-11-14
- 2022-03-31: Long-Term Debt, Maturity, after Year Five $735.00K; Long-Term Debt, Maturity, after Year Five as first filed $850.00K.
- 2021-03-31: Long-Term Debt, Maturity, after Year Five $990.00K.
- 2020-03-31: Long-Term Debt, Maturity, after Year Five $990.00K.
- 2014-09-30: Long-Term Debt, Maturity, after Year Five $44.98K.
| Period end | Long-Term Debt, Maturity, after Year Five | Long-Term Debt, Maturity, after Year Five as first filed |
|---|---|---|
| 2022-03-31 | $735.00K 10-Q · filed 2022-11-14 | $850.00K 10-K · filed 2022-06-29 |
| 2021-03-31 | $990.00K 10-K · filed 2021-06-14 | |
| 2020-03-31 | $990.00K 10-K · filed 2020-06-29 | |
| 2014-09-30 | $44.98K 10-Q · filed 2014-11-14 | |
| 2014-03-31 | $1.67M 10-K · filed 2014-06-30 | |
| 2013-03-31 | $1.76M 10-K · filed 2013-06-21 |